Last reviewed · How we verify
Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
The development of a safe and effective vaccine is the best strategy for preventing the spread of HIV-1. The purpose of this study is to determine the safety and effectiveness of and immune responses to an HIV vaccine regimen in healthy adults at risk for HIV infection.
Details
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| Phase | PHASE2 |
| Status | WITHDRAWN |
Conditions
- HIV Infections
Interventions
- VRC-HIVDNA016-00-VP
- VRC-HIVADV014-00-VP
- VRC-HIVDNA016-00-VP placebo
- VRC-HIVADV014-00-VP placebo